Epsilon M&A Deal Report - MoNo chem-pharm Produkte (Sigmapharm)

Transaction Multiples for the Valuation of Private Companies

Rohto Pharmaceuticals Co > MoNo chem-pharm Produkte (Sigmapharm)

Announced Date : 05 June 2024

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Rohto Pharmaceuticals Co

Target: MoNo chem-pharm Produkte (Sigmapharm)

Target Country: Austria

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Established in 1999,

No EMAT : 117090

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
27/03/2024	Private group led by Carvest, Siparex	Capron Podologie	France	0
04/02/2020	Private Group Led by Ardian, HLD, UI Gestion	Sante Cie	France	0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database